BACKGROUND: Growth differentiation factor 15 (GDF-15) is produced by cardiomyocytes and atherosclerotic lesions under stress conditions. Although higher circulating GDF-15 concentrations are associated with mortality across a spectrum of cardiovascular conditions, the relationship of GDF-15 with atherosclerosis and mortality in the general population remains undefined. METHODS: We measured plasma GDF-15 in 3219 participants of the Dallas Heart Study, a population sample of adults ages 30-65 years (55% women, 49% black). GDF-15 was analyzed in prespecified categories (<1200; 1200-1799; and ≥1800 ng/L) and continuously. End points included prevalent coronary artery calcium (CAC>10 Agatston units), increased CAC (CAC≥100 Agatston units) by electron beam computed tomography, and mortality through a median 7.3 years of follow-up (120 deaths, 48 cardiovascular deaths). RESULTS: Increasing GDF-15 associated with older age, black race, hypertension, diabetes, smoking, left ventricular (LV) mass/body surface area, and worse renal function (P<0.0001 for each). In multivariable models adjusted for traditional risk factors, renal function, and LV mass/body surface area, GDF-15≥1800 ng/L was associated with CAC>10 (odds ratio 2.1; 95% CI 1.2-3.7; P=0.01), CAC≥100 (odds ratio 2.6; 95% CI 1.4-4.9; P=0.002), all-cause mortality (hazard ratio 3.5; 95% CI 2.1-5.9, P<0.0001), and cardiovascular mortality (hazard ratio 2.5; 95% CI 1.1-5.8, P=0.03). Adding log GDF-15 to fully adjusted models modestly improved the c statistic (P=0.025), the integrated discrimination index (0.028; P<0.0001) and the category-less net reclassification index (0.42; P=0.002). These findings remained significant with further adjustment for high-sensitivity C-reactive protein, N-terminal pro-B-type natriuretic peptide, and cardiac troponin T. CONCLUSIONS: GDF-15 is independently associated with subclinical coronary atherosclerosis and mortality, and its potential role for risk stratification in the general population merits further evaluation.
BACKGROUND:Growth differentiation factor 15 (GDF-15) is produced by cardiomyocytes and atherosclerotic lesions under stress conditions. Although higher circulating GDF-15 concentrations are associated with mortality across a spectrum of cardiovascular conditions, the relationship of GDF-15 with atherosclerosis and mortality in the general population remains undefined. METHODS: We measured plasma GDF-15 in 3219 participants of the Dallas Heart Study, a population sample of adults ages 30-65 years (55% women, 49% black). GDF-15 was analyzed in prespecified categories (<1200; 1200-1799; and ≥1800 ng/L) and continuously. End points included prevalent coronary artery calcium (CAC>10 Agatston units), increased CAC (CAC≥100 Agatston units) by electron beam computed tomography, and mortality through a median 7.3 years of follow-up (120 deaths, 48 cardiovascular deaths). RESULTS: Increasing GDF-15 associated with older age, black race, hypertension, diabetes, smoking, left ventricular (LV) mass/body surface area, and worse renal function (P<0.0001 for each). In multivariable models adjusted for traditional risk factors, renal function, and LV mass/body surface area, GDF-15≥1800 ng/L was associated with CAC>10 (odds ratio 2.1; 95% CI 1.2-3.7; P=0.01), CAC≥100 (odds ratio 2.6; 95% CI 1.4-4.9; P=0.002), all-cause mortality (hazard ratio 3.5; 95% CI 2.1-5.9, P<0.0001), and cardiovascular mortality (hazard ratio 2.5; 95% CI 1.1-5.8, P=0.03). Adding log GDF-15 to fully adjusted models modestly improved the c statistic (P=0.025), the integrated discrimination index (0.028; P<0.0001) and the category-less net reclassification index (0.42; P=0.002). These findings remained significant with further adjustment for high-sensitivity C-reactive protein, N-terminal pro-B-type natriuretic peptide, and cardiac troponin T. CONCLUSIONS:GDF-15 is independently associated with subclinical coronary atherosclerosis and mortality, and its potential role for risk stratification in the general population merits further evaluation.
Authors: Lori B Daniels; Paul Clopton; Gail A Laughlin; Alan S Maisel; Elizabeth Barrett-Connor Journal: Circulation Date: 2011-05-02 Impact factor: 29.690
Authors: Qi Ding; Tomas Mracek; Pedro Gonzalez-Muniesa; Katarina Kos; John Wilding; Paul Trayhurn; Chen Bing Journal: Endocrinology Date: 2008-12-12 Impact factor: 4.736
Authors: Tibor Kempf; Stephan von Haehling; Timo Peter; Tim Allhoff; Mariantonietta Cicoira; Wolfram Doehner; Piotr Ponikowski; Gerasimos S Filippatos; Piotr Rozentryt; Helmut Drexler; Stefan D Anker; Kai C Wollert Journal: J Am Coll Cardiol Date: 2007-08-24 Impact factor: 24.094
Authors: Beatriz Bermúdez; Sergio López; Yolanda M Pacheco; José Villar; Francisco J G Muriana; Jöerg D Hoheisel; Andrea Bauer; Rocío Abia Journal: Cardiovasc Res Date: 2008-03-21 Impact factor: 10.787
Authors: Kai C Wollert; Tibor Kempf; Timo Peter; Sylvia Olofsson; Stefan James; Nina Johnston; Bertil Lindahl; Rüdiger Horn-Wichmann; Georg Brabant; Maarten L Simoons; Paul W Armstrong; Robert M Califf; Helmut Drexler; Lars Wallentin Journal: Circulation Date: 2007-02-05 Impact factor: 29.690
Authors: Tibor Kempf; Erik Björklund; Sylvia Olofsson; Bertil Lindahl; Tim Allhoff; Timo Peter; Jörn Tongers; Kai C Wollert; Lars Wallentin Journal: Eur Heart J Date: 2007-10-31 Impact factor: 29.983
Authors: Matthew J Budoff; Khurram Nasir; Robyn L McClelland; Robert Detrano; Nathan Wong; Roger S Blumenthal; George Kondos; Richard A Kronmal Journal: J Am Coll Cardiol Date: 2009-01-27 Impact factor: 24.094
Authors: Kai C Wollert; Tibor Kempf; Bo Lagerqvist; Bertil Lindahl; Sylvia Olofsson; Tim Allhoff; Timo Peter; Agneta Siegbahn; Per Venge; Helmut Drexler; Lars Wallentin Journal: Circulation Date: 2007-09-11 Impact factor: 29.690
Authors: Viji Nair; Cassianne Robinson-Cohen; Michelle R Smith; Keith A Bellovich; Zeenat Yousuf Bhat; Maria Bobadilla; Frank Brosius; Ian H de Boer; Laurent Essioux; Ivan Formentini; Crystal A Gadegbeku; Debbie Gipson; Jennifer Hawkins; Jonathan Himmelfarb; Bryan Kestenbaum; Matthias Kretzler; Maria Chiara Magnone; Kalyani Perumal; Susan Steigerwalt; Wenjun Ju; Nisha Bansal Journal: J Am Soc Nephrol Date: 2017-02-03 Impact factor: 10.121
Authors: Biniyam G Demissei; Gary Freedman; Steven J Feigenberg; John P Plastaras; Amit Maity; Amanda M Smith; Caitlin McDonald; Karyn Sheline; Charles B Simone; Lilie L Lin; Joseph R Carver; Peter Liu; Liyong Zhang; Justin E Bekelman; Bonnie Ky Journal: Int J Radiat Oncol Biol Phys Date: 2018-11-14 Impact factor: 7.038
Authors: Charlotte Andersson; Danielle Enserro; Lisa Sullivan; Thomas J Wang; James L Januzzi; Emelia J Benjamin; Joseph A Vita; Naomi M Hamburg; Martin G Larson; Gary F Mitchell; Ramachandran S Vasan Journal: Atherosclerosis Date: 2016-02-18 Impact factor: 5.162
Authors: Jennifer E Ho; Shih-Jen Hwang; Kai C Wollert; Martin G Larson; Susan Cheng; Tibor Kempf; Ramachandran S Vasan; James L Januzzi; Thomas J Wang; Caroline S Fox Journal: Clin Chem Date: 2013-07-19 Impact factor: 8.327